Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial

Naser Davarzani, Lindsay C Hewitt, Matthew D Hale, Veerle Melotte, Matthew Nankivell, Gordon G A Hutchins, David Cunningham, William H Allum, Ruth E Langley, Shahab Jolani, Heike I Grabsch*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number058
Number of pages8
JournalDiseases of the Esophagus
Volume33
Issue number8
Early online date3 Aug 2020
DOIs
Publication statusPublished - Aug 2020

Keywords

  • esophageal cancer
  • histological heterogeneity
  • neoadjuvant chemotherapy
  • pretreatment biopsy
  • proportion of tumor
  • BARRETTS-ESOPHAGUS
  • ADENOCARCINOMA
  • DIVERSITY
  • PROGRESSION
  • EVOLUTION
  • RESECTION

Cite this